We thank Dr. Conget and colleagues (1) for their comments on our article (2) and congratulate them on their article (3) on insulin pump use in type 2 diabetes, published online in The Lancet. Of course, our article was accepted for publication earlier in the year, and we could not know of their study. Furthermore, while we addressed opportunities and challenges around insulin therapy in type 2 diabetes both for people starting insulin and those optimizing therapy later, we did not address particular insulin regimens or delivery devices and how those impacted these issues. We do acknowledge that such issues are important to people with diabetes using insulin and that insulin pumps alongside other delivery devices and technologies are an appropriate topic for discussion in the future literature.
Article Information
Duality of Interest. No potential conflicts of interest relevant to this article were reported.
